| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2015↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $-0.1B | $0.1B | $-0.0B | $-0.2B | $0.3B | $-0.6B | $0.0B | $0.0B |
| EPS (Basic) | $-0.63 | $0.32 | $-0.11 | $-1.43 | $2.73 | $-5.12 | $0.42 | $0.49 |
| EPS (Diluted) | $-0.63 | $0.32 | $-0.11 | $-1.43 | $2.37 | $-5.12 | $0.38 | $0.46 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2015↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $23.7B | $18.3B | $14.5B | $13.0B | $14.7B | $10.4B | $18.0B | $6.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.3B | $0.2B | $0.3B | $0.3B | $0.5B | $0.5B | $0.2B | $0.2B |
| Total Liabilities | $22.7B | $17.1B | $13.3B | $11.9B | $13.3B | $9.2B | $16.2B | $5.1B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.0B | $1.2B | $1.2B | $1.1B | $1.4B | $1.1B | $1.8B | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2015↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-10.1B | $-5.9B | $-2.0B | $-0.1B | $-5.7B | $-0.5B | $-1.2B | $-1.3B |
| Investing Cash Flow | $4.5B | $2.5B | $0.9B | $0.2B | $1.4B | $4.1B | $1.0B | $0.9B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $5.7B | $3.3B | $1.1B | $-0.3B | $4.3B | $-3.3B | $0.2B | $0.3B |